Recently, there has been a large increase in the number and types of biological products -from therapeutic antibodies to vaccines for the prevention of infectious diseases -that are produced in bioengineered plant systems. We anticipate that this technology will be used increasingly on a commercial
The regulation of biological products
โ Scribed by K. R. Brown
- Book ID
- 105416309
- Publisher
- Springer
- Year
- 1990
- Tongue
- English
- Weight
- 483 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0934-9723
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The third edition of this innovative work again provides a unique perspective on the clinical discovery process by providing input from experts within the NIH on the principles and practice of clinical research. Molecular medicine, genomics, and proteomics have opened vast opportunities for translat
Coordinate production of interleukin-1 (3 (IL-1 (3) and granulocyte macrophagecolony stimulating factor (CM-CSF) or IL-6 by the blast cells of acute myeloblastic leukemia (AML) and normal peripheral blood leukocytes have been previously reported (van der Shoot et al.: